Stockreport

CEL-SCI: Food For Thought Before The Big Day [Seeking Alpha]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Summary CEL-SCI is extremely likely to witness clinical trial success with its only product, Multikine. More than 350,000 patients die each year due to HSNCC. The drug h [Read more]